Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations. We help you understand fair value estimates and potential upside or downside scenarios for any stock.
As of April 13, 2026, Crinetics Pharmaceuticals Inc. (CRNX) trades at a current price of $38.67, marking a 1.95% downward move in recent trading. This analysis outlines key market context, technical support and resistance levels, and potential near-term price scenarios for the biotech stock, with no recent earnings data available for the company at the time of writing. Recent price action for CRNX has been range-bound for much of this month, leading investors and traders to monitor key technical
Is Crinetics (CRNX) Stock Breaking Resistance | Price at $38.67, Down 1.95% - Reversal Setup
CRNX - Stock Analysis
3197 Comments
1617 Likes
1
Francetta
Daily Reader
2 hours ago
As someone new to this, I didn’t realize I needed this info.
👍 108
Reply
2
Charlette
Active Contributor
5 hours ago
This made me pause… for unclear reasons.
👍 279
Reply
3
Vetrice
Regular Reader
1 day ago
Expert US stock margin analysis and operational efficiency metrics to identify companies with improving profitability. We track key performance indicators that often signal fundamental improvement before it shows up in earnings.
👍 143
Reply
4
Kfir
Power User
1 day ago
I don’t know what’s happening, but I’m involved now.
👍 108
Reply
5
Deaudre
Expert Member
2 days ago
Wish I had discovered this earlier.
👍 189
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.